A股異動丨天山生物漲停 豬肉價格持續上漲帶動牛羊肉價格
格隆匯10月25日丨天山生物(300313.SZ)漲停,報6.3元,成交8428萬元,總市值20億元。全國豬價指數從8月初的19上漲至8月末27.05,累計上漲42%;9月豬價高位繼續上漲,但漲幅有所放緩,月底全國豬價指數上漲至29.17左右,華南,華東和西南部分省份的生豬均價均已超過30元/公斤。10月以來,豬價加速上漲,截止10月21日全國豬價指數上漲至38.6,較月初漲幅超36%。豬肉價格上漲也帶動牛羊肉價格上漲。天山生物的主要業務為種牛、奶牛的養殖、銷售和進出口;種羊的養殖、銷售和進出口;凍精、胚胎的生產、銷售和進出口;生鮮牛乳的收購和銷售;飼料種植、加工和銷售;肉類的銷售和進出口業務等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.